Centre Activities
WHO GISRS Surveillance
Training for Influenza Laboratories
Research and Collaborations
Education Opportunities
Centre Publications
Reports and Newsletters


Contact
WHO Collaborating Centre for Reference and Research on Influenza (VIDRL)
Peter Doherty Institute for Infection and Immunity
792 Elizabeth Street
Melbourne VIC 3000 Australia

T +61 3 9342 9300
F +61 3 9342 9329
whoflu@influenzacentre.org


Centre Publications

Click on column headings to sort

Author(s)
Title
Year
Citation
McAuley J, Deng YM, Gilbertson B, Mackenzie-Kludas C, Barr I and Brown LRapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection2017Virol J 14(1): 162.  PubMed link
DOI:10.1186/s12985-017-0827-0
Douglas AP, Trubiano JA, Barr I, Leung V, Slavin MA and Tam CSIbrutinib may impair serological responses to influenza vaccination2017Haematologica 102(10): e397-e399.  PubMed link
DOI:10.3324/haematol.2017.164285
Arnott A, Carville K, Franklin L and Sullivan SGConsecutive influenza infections in both adults and children2017J Infect Dis 215(4): 658-659.  PubMed link
DOI:10.1093/infdis/jix016
Kwok KO, Riley S, Perera R, Wei VWI, Wu P, Wei L, Chu DKW, Barr IG, Malik Peiris JS and Cowling BJRelative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N12017BMC Infect Dis 17(1): 337.  PubMed link
DOI:10.1186/s12879-017-2432-7
Pizzolla A, Nguyen THO, Smith JM, Brooks AG, Kedzieska K, Heath WR, Reading PC and Wakim LMResident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection2017Sci Immunol 2(12).  PubMed link
DOI:10.1126/sciimmunol.aam6970
Pizzolla A, Smith JM, Brooks AG and Reading PCPattern recognition receptor immunomodulation of innate immunity as a strategy to limit the impact of influenza virus2017J Leukoc Biol 101(4): 851-861.  PubMed link
DOI:10.1189/jlb.4MR0716-290R
Pizzolla A, Wang Z, Groom JR, Kedzierska K, Brooks AG, Reading PC and Wakim LMNasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells2017Proc Natl Acad Sci U S A 114(20): 5225-5230.  PubMed link
DOI:10.1073/pnas.1620194114
Horby PW, Laurie KL, Cowling BJ, Engelhardt OG, Sturm-Ramirez K, Sanchez JL, Katz JM, Uyeki TM, Wood J, Van Kerkhove MD, CONSISE Steering CommitteeCONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement2017Influenza Other Respir Viruses 11(1): 2-14.  PubMed link
DOI:10.1111/irv.12411
Leang SK and Hurt AC Fluorescence-based neuraminidase inhibition assay to assess the susceptibility of influenza viruses to the neuraminidase inhibitor class of antivirals2017J Vis Exp(122).  PubMed link
DOI:10.3791/55570
Journal of Visual Experiments link to video
Leung VK, Carolan LA, Worth LJ, Harper SA, Peck H, Tilmanis D, Laurie KL, Slavin MA and Sullivan SGInfluenza vaccination responses: Evaluating impact of repeat vaccination among health care workers2017Vaccine 35(19): 2558-2568.  PubMed link
DOI:10.1016/j.vaccine.2017.03.063
Dalziel AE, Peck HA, Hurt AC, Cooke J and Cassey P Proposed surveillance for Influenza A in feral pigs2016Ecohealth 13(2): 410-414. 
PubMed link
DOI:10.1007/s10393-016-1126-8
Komadina N, Quiñones-Parra SM, Kedzierska K, McCaw JM, Kelso A, Leder K and McVernon JHigh conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant2016J Med Virol 88(10): 1725-1732. 
PubMed link
DOI:10.1002/jmv.24516
Kristensen AB, Lay WN, Ana-Sosa-Batiz F, Vanderven HA, Madhavi V, Laurie KL, Carolan L, Wines BD, Hogarth M, Wheatley AK and Kent SJ Antibody responses with Fc-mediated functions after vaccination of HIV-Infected subjects with trivalent influenza vaccine2016J Virol 90(12): 5724-5734. 
PubMed link
DOI:10.1128/JVI.00285-16
Li C, Hatta M, Burke DF, Ping J, Zhang Y, Ozawa M, Taft AS, Das SC, Hanson AP, Song J, Imai M, Wilker PR, Watanabe T, Watanabe S, Ito M, Iwatsuki-Horimoto K, Russell CA, James SL, Skepner E, Maher EA, Neumann G, Klimov AI, Kelso A, McCauley J, Wang D, Shu Y, Odagiri T, Tashiro M, Xu X, Wentworth DE, Katz JM, Cox NJ, Smith DJ and Kawaoka YSelection of antigenically advanced variants of seasonal influenza viruses2016Nat Microbiol 1(6): 16058. 
PubMed link
DOI:10.1038/nmicrobiol.2016.58
McBride WJ, Abhayaratna WP, Barr I, Booy R, Carapetis J, Carson S, De Looze F, Ellis-Pegler R, Heron L, Karrasch J, Marshall H, McVernon J, Nolan T, Rawlinson W, Reid J, Richmond P, Shakib S, Basser RL, Hartel GF, Lai MH, Rockman S and Greenberg MEEfficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial2016Vaccine 34(41): 4991-4997. 
PubMed link
DOI:10.1016/j.vaccine.2016.08.038
Pennington K, Bareja C, Sullivan SG, Franklin LJ and Raupach JInfluenza surveillance in Australia2016Commun Dis Intell Q Rep 40(3): E315-E316. 
PubMed link
Sullivan SG, Raupach J, Franklin LJ, Pennington K, Bareja C, de Kluyver R and and the National Influenza Surveillance Committee A brief overview of influenza surveillance systems in Australia, 20152016Commun Dis Intell Q Rep 40(3): E351-E355. 
PubMed link
Allen RJ, Koutsakos M, Hurt AC and Kedzierska K Uncomplicated cystitis in an adult male following influenza B virus Infection2017Am J Case Rep 18: 190-193. 
PubMed link
Barr IGAssessing the potential pandemic risk of recent avian influenza viruses2017Eur Respir J 49(3). 
PubMed link
DOI:10.1183/13993003.02517-2016
Yan AW, Cao P, Heffernan JM, McVernon J, Quinn KM, La Gruta NL, Laurie KL and McCaw JMModelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host2017J Theor Biol 413: 34-49. 
PubMed link
DOI:10.1016/j.jtbi.2016.11.008
Barr IG and Wong FYAvian influenza: why the concern?2016Microbiology Australia November. 
Website link
DOI:10.1071/MA16055
Gillespie L, Gerstenberg K, Ana-Sosa-Batiz F, Parsons MS, Farrukee R, Krabbe M, Spann K, Brooks AG, Londrigan SL and Reading PCDC-SIGN and L-SIGN are attachment factors that promote infection of target cells by human metapneumovirus in the presence or absence of cellular glycosaminoglycans2016J Virol 90(17): 7848-7863. 
PubMed link
DOI:10.1128/JVI.00537-16
Hurt AC, Su YC, Aban M, Peck H, Lau H, Baas C, Deng YM, Spirason N, Ellstrom P, Hernandez J, Olsen B, Barr IG, Vijaykrishna D and Gonzalez-Acuna DEvidence for the introduction, reassortment, and persistence of diverse influenza A viruses in Antarctica2016J Virol 90(21): 9674-9682. 
PubMed link
DOI:10.1128/JVI.01404-16
Jelley L, Levy A, Deng YM, Spirason N, Lang J, Buettner I, Druce J, Blyth C, Effler P, Smith D and Barr IGInfluenza C infections in Western Australia and Victoria from 2008 to 20142016Influenza Other Respir Viruses 10(6): 455-461. 
PubMed link
DOI:10.1111/irv.12402
Lau H and Hurt ACAssessment of the RNASound RNA sampling card for the preservation of influenza virus RNA2016Front Microbiol 7: 1736. 
PubMed link
DOI:10.3389/fmicb.2016.01736
Sullivan SG, Cowling BJ and Greenland SFrailty and influenza vaccine effectiveness2016Vaccine 34(39): 4645-4646. 
PubMed link
DOI:10.1016/j.vaccine.2016.08.003
Sullivan SG, Tchetgen Tchetgen EJ and Cowling BJTheoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness2016Am J Epidemiol 184(5): 345-353. 
PubMed link
DOI:10.1093/aje/kww064
Beale DJ, Jones OA, Karpe AV, Dayalan S, Oh DY, Kouremenos KA, Ahmed W and Palombo EAA review of analytical techniques and their application in disease diagnosis in breathomics and salivaomics research2016Int J Mol Sci 18(1). 
PubMed link
DOI:10.3390/ijms18010024
Chua BY, Wong CY, Mifsud EJ, Edenborough KM, Sekiya T, Tan AC, Mercuri F, Rockman S, Chen W, Turner SJ, Doherty PC, Kelso A, Brown LE and Jackson DCInactivated influenza vaccine that provides rapid, innate-immune-system-mediated protection and subsequent long-yerm adaptive immunity2015MBio 6(6): e01024-01015. 
PubMed link
DOI:10.1128/mBio.01024-15
Fielding JE, Levy A, Chilver MB, Deng YM, Regan AK, Grant KA, Stocks NP and Sullivan SGEffectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment2016Vaccine 34(41): 4905-4912. 
PubMed link
DOI:10.1016/j.vaccine.2016.08.067
Kotecha RS, Wadia UD, Jacoby P, Ryan AL, Blyth CC, Keil AD, Gottardo NG, Cole CH, Barr IG and Richmond PCImmunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer2016Cancer Med 5(2): 285-293. 
PubMed link
DOI:10.1002/cam4.596
Moss R, McCaw JM, Cheng AC, Hurt AC and McVernon JReducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context2016BMC Infect Dis 16(1): 552. 
PubMed link
DOI:10.1186/s12879-016-1866-7
Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T and WHO Working GroupStrengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 20142015Vaccine 33(36): 4368-4382. 
PubMed link
DOI:10.1016/j.vaccine.2015.06.090
Foo SS, Reading PC, Jaillon S, Mantovani A and Mahalingam SPentraxins and collectins: friend or foe during pathogen invasion?2015Trends Microbiol 23(12): 799-811. 
PubMed link
DOI:10.1016/j.tim.2015.09.006
Grillo VL, Arzey KE, Hansbro PM, Hurt AC, Warner S, Bergfeld J, Burgess GW, Cookson B, Dickason CJ, Ferenczi M, Hollingsworth T, Hoque M, Jackson RB, Klaassen M, Kirkland PD, Kung NY, Lisovski S, O'Dea MA, O'Riley K, Roshier D, Skerratt LF, Tracey JP, Wang X, Woods R and Post LAvian influenza in Australia: a summary of 5 years of wild bird surveillance2015Aust Vet J 93(11): 387-393. 
PubMed link
DOI:10.1111/avj.12379
Ng WC, Londrigan SL, Nasr N, Cunningham AL, Turville S, Brooks AG and Reading PCThe C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus2015J Virol 90(1): 206-221. 
PubMed link
DOI:10.1128/JVI.01447-15
Petrie SM, Butler J, Barr IG, McVernon J, Hurt AC and McCaw JMQuantifying relative within-host replication fitness in influenza virus competition experiments2015J Theor Biol 382: 259-271. 
PubMed link
DOI:10.1016/j.jtbi.2015.07.003
Ana-Sosa-Batiz F, Vanderven H, Jegaskanda S, Johnston A, Rockman S, Laurie K, Barr I, Reading P, Lichtfuss M and Kent SJInfluenza-Specific Antibody-Dependent Phagocytosis2016PLoS One 11(4): e0154461. 
PubMed link
DOI:10.1371/journal.pone.0154461
Carolan LA, Rockman S, Borg K, Guarnaccia T, Reading P, Mosse J, Kelso A, Barr I and Laurie KLCharacterization of the localized immune response in the respiratory tract of ferrets following infection with influenza A and B viruses2016J Virol 90(6): 2838-2848. 
PubMed link
DOI:10.1128/JVI.02797-15
Edenborough KM, Lowther S, Laurie K, Yamada M, Long F, Bingham J, Payne J, Harper J, Haining J, Arkinstall R, Gilbertson B, Middleton D and Brown LEPredicting disease severity and viral spread of H5N1 influenza virus in ferrets in the context of natural exposure routes2016J Virol 90(4): 1888-1897. 
PubMed link
DOI:10.1128/JVI.01878-15
Feng S, Cowling BJ and Sullivan SGInfluenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings2016Vaccine 34(14): 1672-1679. 
PubMed link
DOI:10.1016/j.vaccine.2016.02.039
FitzPatrick M, Royce SG, Langenbach S, McQualter J, Reading PC, Wijburg O, Anderson GP, Stewart A, Bourke J and Bozinovski SNeonatal pneumococcal colonisation caused by influenza A infection alters lung function in adult mice2016Sci Rep 6: 22751. 
PubMed link
DOI:10.1038/srep22751
Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG and Petrovsky NHuman Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax delta inulin adjuvant2016Vaccine 34(33): 3780-3786. 
PubMed link
DOI:10.1016/j.vaccine.2016.05.071
Hurt AC, Besselaar TG, Daniels RS, Ermetal B, Fry A, Gubareva L, Huang W, Lackenby A, Lee RT, Lo J, Maurer-Stroh S, Nguyen HT, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Tashiro M, Tilmanis D, Wang D, Zhang W and Meijer AGlobal update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-20152016Antiviral Res 132: 178-185. 
PubMed link
DOI:10.1016/j.antiviral.2016.06.001
Hurt AC and Kelly HDebate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza2016Emerg Infect Dis 22(6): 949-955. 
PubMed link
DOI:10.3201/eid2206.151037
Job ER, Pizzolla A, Nebl T, Short KR, Deng YM, Carolan L, Laurie KL, Brooks AG and Reading PCNeutralizing inhibitors in the airways of naive ferrets do not play a major role in modulating the virulence of H3 subtype influenza A viruses2016Virology 494: 143-157. 
PubMed link
DOI:10.1016/j.virol.2016.01.024
Leung VK, Cowling BJ, Feng S and Sullivan SGConcordance of interim and final estimates of influenza vaccine effectiveness: a systematic review2016Euro Surveill 21(16). 
PubMed link
DOI:10.2807/1560-7917.ES.2016.21.16.30202
Mifsud EJ, Tan AC, Reading PC and Jackson DCMapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam(2)Cys2016Immunol Cell Biol 94(2): 169-176. 
PubMed link
DOI:10.1038/icb.2015.81
Milne GJ, Halder N, Kelso JK, Barr IG, Moyes J, Kahn K, Twine R and Cohen CTrivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study2016Influenza Other Respir Viruses 10(4): 324-332. 
PubMed link
DOI:10.1111/irv.12367
Nguyen ML, Hatton L, Li J, Olshansky M, Kelso A, Russ BE and Turner SJDynamic regulation of permissive histone modifications and GATA3 binding underpin acquisition of granzyme A expression by virus-specific CD8(+) T cells2016Eur J Immunol 46(2): 307-318. 
PubMed link
DOI:10.1002/eji.201545875
Ren B, McKinstry WJ, Pham T, Newman J, Layton DS, Bean AG, Chen Z, Laurie KL, Borg K, Barr IG and Adams TEStructural and functional characterisation of ferret interleukin-22016Dev Comp Immunol 55: 32-38. 
PubMed link
DOI:10.1016/j.dci.2015.10.007
Sullivan SG, Carville KS, Chilver M, Fielding JE, Grant KA, Kelly H, Levy A, Stocks NP, Tempone SS and Regan AKPooled influenza vaccine effectiveness estimates for Australia, 2012-20142016Epidemiol Infect 144(11): 2317-2328. 
PubMed link
DOI:10.1017/S0950268816000819
Tang FS, Van Ly D, Spann K, Reading PC, Burgess JK, Hartl D, Baines KJ and Oliver BGDifferential neutrophil activation in viral infections: Enhanced TLR-7/8-mediated CXCL8 release in asthma2016Respirology 21(1): 172-179. 
PubMed link
DOI:10.1111/resp.12657
Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS and Kent SJWhat lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins2016EBioMedicine 8: 277-290. 
PubMed link
DOI:10.1016/j.ebiom.2016.04.029
Gillespie L, Roosendahl P, Ng WC, Brooks AG, Reading PC and Londrigan SLEndocytic function is critical for influenza A virus infection via DC-SIGN and L-SIGN 2016 Sci Rep 6: 19428. 
PubMed link
DOI:10.1038/srep19428
Barr IG, Vijaykrishna D and Sullivan SGDifferential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season2016Euro Surveill 21(4). 
PubMed link
DOI:10.2807/1560-7917.ES.2016.21.4.30118
Fielding JE, Regan AK, Dalton CB, Chilver MB and Sullivan SGHow severe was the 2015 influenza season in Australia?2016Med J Aust 204(2): 60-61. 
PubMed link
Oh DY and Hurt ACUsing the ferret as an animal model for investigating influenza antiviral effectiveness2016Front Microbiol 7: 80. 
PubMed link
DOI:10.3389/fmicb.2016.00080
Eichelberger MC, Couzens L, Gao Y, Levine M, Katz J, Wagner R, Thompson CI, Hoschler K, Laurie K, Bai T, Engelhardt OG and Wood JComparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity 2016 Vaccine 34(4): 458-465. 
PubMed link
DOI:10.1016/j.vaccine.2015.12.022
Ng WC, Londrigan SL, Nasr N, Cunningham AL, Turville S, Brooks AG and Reading PCThe C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus 2016 J Virol 90(1): 206-221. 
PubMed link
DOI:10.1128/JVI.01447-15
Londrigan SL, Short KR, Ma J, Gillespie L, Rockman SP, Brooks AG and Reading PCInfection of mouse macrophages by seasonal influenza viruses can be restricted at the level of virus entry and at a late stage in the virus life cycle2015J Virol 89(24): 12319-12329. 
PubMed link
DOI:10.1128/JVI.01455-15
Laurie KL, Guarnaccia TA, Carolan LA, Yan AW, Aban M, Petrie S, Cao P, Heffernan JM, McVernon J, Mosse J, Kelso A, McCaw JM and Barr IGInterval between infections and viral hierarchy are determinants of viral interference following influenza virus infection in a ferret model 2015 J Infect Dis 212(11): 1701-1710. 
PubMed link
DOI:10.1093/infdis/jiv260
Mohr PG, Deng YM and McKimm-Breschkin JLThe neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding 2015 Virol J 12: 67. 
PubMed link
DOI:10.1186/s12985-015-0295-3
Farrukee R, Leang SK, Butler J, Lee RT, Maurer-Stroh S, Tilmanis D, Sullivan S, Mosse J, Barr IG and Hurt ACInfluenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility 2015 J Antimicrob Chemother 70(7): 2004-2012. 
PubMed link
DOI:10.1093/jac/dkv065
Sullivan SG, Chow MK, Barr IG and Kelso AInfluenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2014 2015 Commun Dis Intell Q Rep 39(4): E602-611. 
PubMed link
Sullivan SG and Cowling BJ"Crude Vaccine Effectiveness" is a misleading term in test-negative studies of influenza vaccine effectiveness 2015 Epidemiology 26(5): e60. 
PubMed link
DOI:10.1097/EDE.0000000000000343
Laurie KL, Engelhardt OG, Wood J, Heath A, Katz JM, Peiris M, Hoschler K, Hungnes O, Zhang W and Van Kerkhove MDInternational laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE 2015 Clin Vaccine Immunol 22(8): 957-964. 
PubMed link
DOI:10.1128/CVI.00278-15
Infusini G, Smith JM, Yuan H, Pizzolla A, Ng WC, Londrigan SL, Haque A, Reading PC, Villadangos JA and Wakim LMRespiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming 2015 PLoS One 10(11): e0143539. 
PubMed link
DOI:10.1371/journal.pone.0143539
Little K, Leang SK, Butler J, Baas C, Harrower B, Mosse J, Barr IG and Hurt ACZanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring 2015 Euro Surveill 20(45). 
PubMed link
DOI:10.2807/1560-7917.ES.2015.20.45.30060
Londrigan SL, Tate MD, Job ER, Moffat JM, Wakim LM, Gonelli CA, Purcell DF, Brooks AG, Villadangos JA, Reading PC and Mintern JDEndogenous murine BST-2/Tetherin is not a major restriction factor of influenza A virus infection 2015 PLoS One 10(11): e0142925. 
PubMed link
DOI:10.1371/journal.pone.0142925
Wang J, Moore NE, Deng YM, Eccles DA and Hall RJMinION nanopore sequencing of an influenza genome 2015 Front Microbiol 6: 766. 
PubMed link
DOI:10.3389/fmicb.2015.00766
Cao P, Yan AW, Heffernan JM, Petrie S, Moss RG, Carolan LA, Guarnaccia TA, Kelso A, Barr IG, McVernon J, Laurie KL and McCaw JMInnate immunity and the inter-exposure interval determine the dynamics of secondary influenza virus infection and explain observed viral hierarchies 2015 PLoS Comput Biol 11(8): e1004334. 
PubMed link
DOI:10.1371/journal.pcbi.1004334
Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, Klimov A, Lewis NS, Li X, McCauley JW, Odagiri T, Potdar V, Rambaut A, Shu Y, Skepner E, Smith DJ, Suchard MA, Tashiro M, Wang D, Xu X, Lemey P and Russell CAGlobal circulation patterns of seasonal influenza viruses vary with antigenic drift 2015 Nature 523(7559): 217-220. 
PubMed link
DOI:10.1038/nature14460
Deng YM, Spirason N, Iannello P, Jelley L, Lau H and Barr IGA simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses 2015 J Clin Virol 68: 43-48. 
PubMed link
DOI:10.1016/j.jcv.2015.04.019
Panozzo J, Oh DY, Margo K, Morton DA, Piedrafita D, Mosse J and Hurt ACEvaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infection 2015 Antiviral Res 120: 66-71. 
PubMed link
DOI:10.1016/j.antiviral.2015.05.007
Su YC, Bahl J, Joseph U, Butt KM, Peck HA, Koay ES, Oon LL, Barr IG, Vijaykrishna D and Smith GJPhylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection 2015 Nat Commun 6: 7952. 
PubMed link
DOI:10.1038/ncomms8952
Bird NL, Olson MR, Hurt AC, Oshansky CM, Oh DY, Reading PC, Chua BY, Sun Y, Tang L, Handel A, Jackson DC, Turner SJ, Thomas PG and Kedzierska KOseltamivir prophylaxis reduces inflammation and facilitates establishment of cross-strain protective T cell memory to influenza viruses 2015 PLoS One 10(6): e0129768. 
PubMed link
DOI:10.1371/journal.pone.0129768
Fox A, Mai le Q, Thanh le T, Wolbers M, Le Khanh Hang N, Thai PQ, Thi Thu Yen N, Minh Hoa le N, Bryant JE, Duong TN, Thoang DD, Barr IG, Wertheim H, Farrar J, Hien NT and Horby PHemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection 2015 J Infect 70(2): 187-196. 
PubMed link
DOI:10.1016/j.jinf.2014.09.003
Hurt AC, Hui DS, Hay A and Hayden FGOverview of the 3rd isirv-Antiviral Group Conference--advances in clinical management 2015 Influenza Other Respir Viruses 9(1): 20-31. 
PubMed link
DOI:10.1111/irv.12293
Jiang L, Lee VJ, Lim WY, Chen MI, Chen Y, Tan L, Lin RT, Leo YS, Barr I and Cook ARPerformance of case definitions for influenza surveillance 2015 Euro Surveill 20(22). 
PubMed link
Patterson Ross Z, Komadina N, Deng YM, Spirason N, Kelly HA, Sullivan SG, Barr IG and Holmes ECInter-seasonal influenza is characterized by extended virus transmission and persistence 2015 PLoS Pathog 11(6): e1004991. 
PubMed link
DOI:10.1371/journal.ppat.1004991
Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, Fry A, Gregory V, Leang SK, Huang W, Lo J, Pereyaslov D, Siqueira MM, Wang D, Mak GC, Zhang W, Daniels RS, Hurt AC and Tashiro MGlobal update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014 2015 Antiviral Res 117: 27-38. 
PubMed link
DOI:10.1016/j.antiviral.2015.02.003
Barr IG and Kelly HAOseltamivir reduces clinical illness in households in Bangladesh 2015 Lancet Infect Dis 15(6): 617-619. 
PubMed link
DOI:10.1016/S1473-3099(15)70084-8
Hsu AC, Starkey MR, Hanish I, Parsons K, Haw TJ, Howland LJ, Barr I, Mahony JB, Foster PS, Knight DA, Wark PA and Hansbro PMTargeting PI3K-p110alpha Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease 2015 Am J Respir Crit Care Med 191(9): 1012-1023. 
PubMed link
DOI:10.1164/rccm.201501-0188OC
Proudfoot O, Esparon S, Tang CK, Laurie K, Barr I and Pietersz GMannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung 2015 BMC Infect Dis 15(1): 101. 
PubMed link
DOI:10.1186/s12879-015-0838-7
Foo SS, Chen W, Taylor A, Sheng KC, Yu X, Teng TS, Reading PC, Blanchard H, Garlanda C, Mantovani A, Ng LF, Herrero LJ and Mahalingam SRole of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation 2015 PLoS Pathog 11(2): e1004649. 
PubMed link
DOI:10.1371/journal.ppat.1004649
Oh DY, Barr IG and Hurt ACA novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity 2015 PLoS One 10(3): e0118780. 
PubMed link
DOI:10.1371/journal.pone.0118780
Lee HK, Tang JW, Loh TP, Hurt AC, Oon LL and Koay ESMolecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013 2015 PLoS One 10(1): e0117822. 
PubMed link
DOI:10.1371/journal.pone.0117822
Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, Stockwell TB, Fedorova NB, Zhou B, Spirason N, Kuhnert D, Boskova V, Stadler T, Costa AM, Dwyer DE, Huang QS, Jennings LC, Rawlinson W, Sullivan SG, Hurt AC, Maurer-Stroh S, Wentworth DE, Smith GJ and Barr IThe contrasting phylodynamics of human influenza B viruses 2015 Elife 4. 
PubMed link
DOI:10.7554/eLife.05055
Carville KS, Grant KA, Sullivan SG, Fielding JE, Lane CR, Franklin L, Druce J and Kelly HAUnderstanding influenza vaccine protection in the community: An assessment of the 2013 influenza season in Victoria, Australia 2015 Vaccine 33(2): 341-345. 
PubMed link
DOI:10.1016/j.vaccine.2014.11.019
Donis RO, Influenza Cell Culture Working GroupPerformance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing 2014 Vaccine 32(48): 6583-6590. 
PubMed link
DOI:10.1016/j.vaccine.2014.06.045
Hurt ACThe epidemiology and spread of drug resistant human influenza viruses 2014 Curr Opin Virol 8: 22-29. 
PubMed link
DOI:10.1016/j.coviro.2014.04.009
Jegaskanda S, Vandenberg K, Laurie KL, Loh L, Kramski M, Winnall WR, Kedzierska K, Rockman S and Kent SJCross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses 2014 J Infect Dis 210(11): 1811-1822. 
PubMed link
DOI:10.1093/infdis/jiu334
Meijer A, Rebelo-de-Andrade H, Correia V, Besselaar T, Drager-Dayal R, Fry A, Gregory V, Gubareva L, Kageyama T, Lackenby A, Lo J, Odagiri T, Pereyaslov D, Siqueira MM, Takashita E, Tashiro M, Wang D, Wong S, Zhang W, Daniels RS and Hurt ACGlobal update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013 2014 Antiviral Res 110: 31-41. 
PubMed link
DOI:10.1016/j.antiviral.2014.07.001
Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, Arkinstall R, Kelso A, McVernon J, Barr IG, Middleton D and Hurt ACEvaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact 2014 J Antimicrob Chemother 69(9): 2458-2469. 
PubMed link
DOI:10.1093/jac/dku146
Perera HK, Vijaykrishna D, Premarathna AG, Jayamaha CJ, Wickramasinghe G, Cheung CL, Yeung MF, Poon LL, Perera AK, Barr IG, Guan Y and Peiris MMolecular Epidemiology of Influenza A(H1N1)pdm09 Virus among Humans and Swine, Sri Lanka 2014 Emerg Infect Dis 20(12): 2080-2084. 
PubMed link
DOI:10.3201/eid2012.140842
Russ BE, Olshanksy M, Smallwood HS, Li J, Denton AE, Prier JE, Stock AT, Croom HA, Cullen JG, Nguyen ML, Rowe S, Olson MR, Finkelstein DB, Kelso A, Thomas PG, Speed TP, Rao S and Turner SJDistinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation 2014 Immunity 41(5): 853-865. 
PubMed link
DOI:10.1016/j.immuni.2014.11.001
Schultz-Cherry S, Webby RJ, Webster RG, Kelso A, Barr IG, McCauley JW, Daniels RS, Wang D, Shu Y, Nobusawa E, Itamura S, Tashiro M, Harada Y, Watanabe S, Odagiri T, Ye Z, Grohmann G, Harvey R, Engelhardt O, Smith D, Hamilton K, Claes F and Dauphin GInfluenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness 2014 MBio 5(6). 
PubMed link
DOI:10.1128/mBio.02430-14
Sullivan SG, Feng S and Cowling BJPotential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review 2014 Expert Rev Vaccines 13(12): 1571-1591. 
PubMed link
DOI:10.1586/14760584.2014.966695
Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NM, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, Le TT, van der Net G, Skepner E, Russell CA, Kaplan TD, Rimmelzwaan GF, Masurel N, de Jong JC, Palache A, Beyer WE, Le QM, Nguyen TH, Wertheim HF, Hurt AC, Osterhaus AD, Barr IG, Fouchier RA, Horby PW and Smith DJAntibody landscapes after influenza virus infection or vaccination 2014 Science 346(6212): 996-1000. 
PubMed link
DOI:10.1126/science.1256427
Horm SV, Mardy S, Rith S, Ly S, Heng S, Vong S, Kitsutani P, Ieng V, Tarantola A, Sar B, Chea N, Sokhal B, Barr I, Kelso A, Horwood PF, Timmermans A, Hurt A, Lon C, Saunders D, Ung SA, Asgari N, Roces MC, Touch S, Komadina N and Buchy PEpidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011 2014 PLoS One 9(10): e110713. 
PubMed link
DOI:10.1371/journal.pone.0110713
Hsu JP, Zhao X, Chen MI, Cook AR, Lee V, Lim WY, Tan L, Barr IG, Jiang L, Tan CL, Phoon MC, Cui L, Lin R, Leo YS and Chow VT Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore 2014 BMC Infect Dis 14: 414. 
PubMed link
DOI: 10.1186/1471-2334-14-414
Levy A, Sullivan SG, Tempone SS, Wong KL, Regan AK, Dowse GK, Effler PV and Smith DWInfluenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012 2014 Vaccine. 
PubMed link
DOI: 10.1016/j.vaccine.2014.08.066
Carolan LA, Butler J, Rockman S, Guarnaccia T, Hurt AC, Reading P, Kelso A, Barr I and Laurie KL TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses 2014 J Virol Methods 205C: 38-52. 
PubMed link
DOI:10.1016/j.jviromet.2014.04.014
Jegaskanda S, Reading PC and Kent SJInfluenza-Specific Antibody-Dependent Cellular Cytotoxicity: Toward a Universal Influenza Vaccine 2014 J Immunol 193(2): 469-475. 
PubMed link
DOI:10.4049/jimmunol.1400432
Mackenzie JS, Kelso A and Hampson AInfluenza 2014 Microbiol Aus(3): 133-137. Online link
Sullivan SG and Barr IGCommunicating the imperfect protection from today's influenza vaccines 2014 Australas Epidemiol 21(1): 40-43. 
Sullivan SG, Chilver MB, Higgins G, Cheng AC and Stocks NPInfluenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network 2014 Med J Aust 201(2): 109-111. 
PubMed link
DOI:10.5694/mja14.00106
Turner SJ, Doherty PC and Kelso ACell-mediated immunity 2013 Textbook of Influenza. R. G. Webster, A. S. Monto, T. J. Braciale and R. A. Lamb (eds), Wiley-Blackwell: 298-310. Online link
Harland KL, Day EB, Apte SH, Russ BE, Doherty PC, Turner SJ and Kelso AEpigenetic plasticity of Cd8a locus during CD8(+) T-cell development and effector differentiation and reprogramming 2014 Nat Commun 5: 3547. 
PubMed link
DOI:10.1038/ncomms4547
Chen MI, Cook AR, Lim WY, Lin R, Cui L, Barr IG, Kelso A, Chow VT, Leo YS, Hsu JP, Shaw R, Chew S, Yap JK, Phoon MC, Koh HW, Zheng H, Tan L and Lee VJFactors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore 2013 Influenza Other Respir Viruses 7(6): 1380-1389. 
PubMed link
DOI:10.1111/irv.12129
Deng YM, Iannello P, Caldwell N, Jelley L, Komadina N, Baas C, Kelso A and Barr IGThe use of pyrosequencer-generated sequence-signatures to identify the influenza B-lineage and the subclade of the B/Yamataga-lineage viruses from currently circulating human influenza B viruses 2013 J Clin Virol 58(1): 94-99. 
PubMed link
DOI:10.1016/j.jcv.2013.04.018
Barr IGWHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013 2014 Vaccine. 
PubMed link
DOI:10.1016/j.vaccine.2014.02.014
Butler J, Hooper KA, Petrie S, Lee R, Maurer-Stroh S, Reh L, Guarnaccia T, Baas C, Xue L, Vitesnik S, Leang SK, McVernon J, Kelso A, Barr IG, McCaw JM, Bloom JD and Hurt ACEstimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses 2014 PLoS Pathog 10(4): e1004065. 
PubMed link
DOI:10.1371/journal.ppat.1004065
Dewar B, Barr I and Robinson PHospital capacity and management preparedness for pandemic influenza in Victoria 2014 Aust N Z J Public Health 38(2): 184-190. 
PubMed link
DOI:10.1111/1753-6405.12170
Hurt AC, Vijaykrishna D, Butler J, Baas C, Maurer-Stroh S, Silva-de-la-Fuente MC, Medina-Vogel G, Olsen B, Kelso A, Barr IG and Gonzalez-Acuna DDetection of evolutionarily distinct avian influenza A viruses in Antarctica 2014 MBio 5(3). 
PubMed link
DOI:10.1128/mBio.01098-14
Laurie KL, Engelhardt OG, Wood J and Van Kerkhove MDGlobal seroepidemiology: value and limitations 2014 Clinical Insights: Influenza Surveillance J. Oxford. eBook, Future Medicine Ltd: 51-66. 
Online link
DOI:10.2217/ebo.13.504
Leang SK, Kwok S, Sullivan SG, Maurer-Stroh S, Kelso A, Barr IG and Hurt ACPeramivir and laninamivir susceptibility of circulating influenza A and B viruses 2014 Influenza Other Respir Viruses 8(2): 135-139. 
PubMed link
Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, Londrigan SL and Reading PCThe macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus 2014 J Virol 88(3): 1659-1672. 
PubMed link
DOI:10.1128/JVI.02014-13
Oh DY and Hurt ACA review of the antiviral susceptibility of human and avian influenza viruses over the last decade 2014 Scientifica (Cairo) 2014: 430629. 
PubMed link
DOI:10.1155/2014/430629
Short KR, Vissers M, de Kleijn S, Zomer AL, Kedzierska K, Grant E, Reading PC, Hermans PW, Ferwerda G and Diavatopoulos DABacterial lipopolysaccharide inhibits influenza virus infection of human macrophages and the consequent induction of CD8+ T cell immunity 2014 J Innate Immun 6(2): 129-139. 
PubMed link
DOI:10.1159/000353905
Short KR, von Kockritz-Blickwede M, Langereis JD, Chew KY, Job ER, Armitage CW, Hatcher B, Fujihashi K, Reading PC, Hermans PW, Wijburg OL and Diavatopoulos DAAntibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media 2014 Infect Immun 82(1): 364-370. 
PubMed link
DOI:10.1128/IAI.01104-13
Sullivan SG, Komadina N, Grant K, Jelley L, Papadakis G and Kelly HInfluenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match 2014 J Med Virol 86(6): 1017-1025. 
PubMed link
DOI:10.1002/jmv.23847
Tate MD, Job ER, Deng YM, Gunalan V, Maurer-Stroh S and Reading PCPlaying hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection 2014 Viruses 6(3): 1294-1316. 
PubMed link
DOI:10.3390/v6031294
Zhou B, Lin X, Wang W, Halpin RA, Bera J, Stockwell TB, Barr IG and Wentworth DEUniversal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics 2014 J Clin Microbiol 52(5): 1330-1337. 
PubMed link
DOI:10.1128/JCM.03265-13
Komadina N, McVernon J, Hall R and Leder K A Historical Perspective of Influenza A(H1N2) Virus 2014 Emerg Infect Dis. 20(1):6-12. PubMed link
DOI:10.3201/eid2001.121848
Job ER, Bottazzi B, Short KR, Deng YM, Mantovani A, Brooks AG and Reading PC A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice 2014 J Immunol. 2014 Jan 1;192(1):271-81. PubMed link
DOI:10.4049/jimmunol.1301814
McVernon J, Laurie K, Faddy H, Irving D, Nolan T, Barr IG and Kelso A Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia 2013 Influenza Other Respir Viruses. 2013 Dec 31. PubMed link
DOI:10.1111/irv.12225
Short KR, Grant EJ, Vissers M, Reading PC, Diavatopoulos DA and Kedzierska K A novel method linking antigen presentation by human monocyte-derived macrophages to CD8(+) T cell polyfunctionality 2013 Front Immunol. 2013 Nov 21;4:389. PubMed link
DOI:10.3389/fimmu.2013.00389
Kelly HA, Grant KA, Tay EL, Franklin L and Hurt AC The significance of increased influenza notifications during spring and summer of 2010-11 in Australia 2013 Influenza Other Respir Viruses. 7(6):1136-41. PubMed link
DOI:10.1111/irv.12057
Short KR, Vissers M, de Kleijn S, Zomer AL, Kedzierska K, Grant E, Reading PC, Hermans PW, Ferwerda G and Diavatopoulos DA Bacterial lipopolysaccharide inhibits influenza virus infection of human macrophages and the consequent induction of CD8+ T cell immunity 2013 J Innate Immun. PubMed link
DOI:10.1159/000353905
Jegaskanda S, Amarasena TH, Laurie KL, Tan HX, Butler J, Parsons MS, Alcantara S, Petravic J, Davenport MP, Hurt AC, Reading PC and Kent SJ Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques 2013 J Virol. 87(24):13706-18. PubMed link
DOI:10.1128/jvi.01666-13
Short KR, von Köckritz-Blickwede M, Langereis JD, Chew KY, Job ER, Armitage CW, Hatcher B, Fujihashi K, Reading PC, Hermans PW, Wijburg OL and Diavatopoulos DA Antibodies mediate the formation of neutrophil extracellular traps (NETs) in the middle ear and facilitate secondary pneumococcal otitis media 2013 Infect. Immun. PubMed link
DOI:10.1128/iai.01104-13
Valkenburg SA, Quiñones-Parra S, Gras S, Komadina N, McVernon J, Wang Z, Halim H, Iannello P, Cole C, Laurie K, Kelso A, Rossjohn J, Doherty PC, Turner SJ and Kedzierska K Acute emergence and reversion of influenza A virus quasispecies within CD8(+) T cell antigenic peptides 2013 Nat Commun. 4:2663. PubMed link
DOI:10.1038/ncomms3663
Job ER, Bottazzi B, Gilbertson B, Edenborough KM, Brown LE, Mantovani A, Brooks AG and Reading PC Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses 2013 PLoS One. 8(3):e59623. PubMed link
DOI:10.1371/journal.pone.0059623
Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, Londrigan SL and Reading PC The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus 2013 J Virol. PubMed link
DOI:10.1128/jvi.02014-13
Jegaskanda S, Laurie KL, Amarasena TH, Winnall WR, Kramski M, De Rose R, Barr IG, Brooks AG, Reading PC and Kent SJ Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1 2013 J Infect Dis. 208(7):1051-61. PubMed link
DOI:10.1093/infdis/jit294
Doyle TM, Li C, Bucher DJ, Hashem AM, Van Domselaar G, Wang J, Farnsworth A, She YM, Cyr T, He R, Brown EG, Hurt AC, and Li X A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains 2013 Biochem Biophys Res Commun. 441(1):226-9. PubMed link
DOI:10.1016/j.bbrc.2013.10.041
Vijaykrishna D, Deng YM, Su YC, Fourment M, Iannello P, Arzey GG, Hansbro PM, Arzey KE, Kirkland PD, Warner S, O'Riley K, Barr IG, Smith GJ and Hurt AC The recent establishment of North American H10 lineage influenza viruses in Australian wild waterfowl and the evolution of Australian avian influenza viruses 2013 J Virol. 87(18):10182-9. PubMed link
DOI:10.1128/jvi.03437-12
Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA and Smith DJ Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution 2013 Science. 342(6161):976-9. PubMed link
DOI:10.1126/science.1244730
Farrukee R, Mosse J and Hurt AC Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses 2013 Expert Rev Infect Ther. 11(11):1135-45. PubMed link
DOI:10.1586/14787210.2013.842466
Members of the Western Pacific Region Global Influenza Surveillance and Response System, this included contributing authors from WHO Collaborating Centre for Reference and Research on Influenza, Melbourne: Barr IG, Hurt AC, Kelso A, Reading P and Sullivan S Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region 2013 WPSAR. (3):51-59. Available online
DOI:10.5365/WPSAR.2013.4.1.009
Doyle TM, Hashem AM, Li C, Van Domselaar G, Larocque L, Wang J, Smith D, Cyr T, Farnsworth A, He R, Hurt AC, Brown EG and Li X Universal anti-neuraminidase antibody inhibiting all influenza A subtypes 2013 Antiviral Res. 100(2):567-74. PubMed link
DOI:10.1016/j.antiviral.2013.09.018
Hurt AC, Ison MG, Hayden FG and Hay AJ Second isirv antiviral group conference: overview 2013 Influenza Other Respir Viruses. 7 Suppl 3:1-7. PubMed link
DOI:10.1111/irv.12207
Fielding J, Grant K, Franklin L, Sullivan SG, Papadakis G, Kelly H and Cheng A Epidemiology of the 2012 influenza season in Victoria, Australia 2013 WPSAR. 4(3):42-50. Available online
DOI:10.5365/wpsar.2013.4.2.007
Sullivan SG and Kelly H Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required 2013 Clin Infect Dis. 57(3):474-6. PubMed link
DOI:10.1093/cid/cit255
Sullivan SG, Tay EL and Kelly H Variable definitions of the influenza season and their impact on vaccine effectiveness estimates 2013 Vaccine. 31(40):4280-3. PubMed link
DOI:10.1016/j.vaccine.2013.06.103
Sullivan SG, Komadina N, Grant K, Jelley L, Papadakis G and Kelly H Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: Influences of waning immunity and vaccine match 2013 J Med Virol. doi: 10.1002/jmv.23847 Available online
DOI:10.1002/jmv.2384
Sullivan SG and Kelly H Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia 2013 Euro Surveill. 18(41):20605.  PubMed link
Kelly HA, Sullivan SG, Grant KA and Fielding JE Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011 2012 Influenza Other Respi Viruses: doi: 10.1111/irv.12018. 
PubMed link
DOI:10.1111/irv.12018
Trauer JM, Bandaranayake D, Booy R, Chen MI, Cretikos M, Dowse GK, Dwyer DE, Greenberg ME, Huang QS, Khandaker G, Kok J, Laurie KL, Lee VJ, McVernon J, Walter S and Markey PG Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore 2013 Emerg Infect Dis 19(1): 92-101. 
PubMed link
DOI:10.3201/eid1901.111643
Baas C, Barr I, Fouchier R, Kelso A and Hurt A A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013 2013 Euro Surveill 18(21). 
PubMed link
Sam IC, Shaw R, Chan YF, Hooi PS, Hurt AC and Barr IG Seroprevalence of seasonal and pandemic influenza A in Kuala Lumpur, Malaysia in 2008-2010 2013 J Med Virol 85(8): 1420-1425. 
PubMed link
DOI:10.1002/jmv.23622
Sullivan SG and Greenland S Bayesian regression in SAS software 2013 Int J Epidemiol 42(1): 308-317. 
PubMed link
DOI:10.1093/ije/dys213
Olver S, Apte SH, Baz A, Kelso A and Kienzle N Interleukin-4-induced loss of CD8 expression and cytolytic function in effector CD8 T cells persists long term in vivo 2013 Immunology 139(2): 187-196. 
PubMed link
DOI:10.1111/imm.12068
Leang SK, Deng YM, Shaw R, Caldwell N, Iannello P, Komadina N, Buchy P, Chittaganpitch M, Dwyer DE, Fagan P, Gourinat AC, Hammill F, Horwood PF, Huang QS, Ip PK, Jennings L, Kesson A, Kok T, Kool JL, Levy A, Lin C, Lindsay K, Osman O, Papadakis G, Rahnamal F, Rawlinson W, Redden C, Ridgway J, Sam IC, Svobodova S, Tandoc A, Wickramasinghe G, Williamson J, Wilson N, Yusof MA, Kelso A, Barr IG and Hurt AC Influenza antiviral resistance in the Asia-Pacific region during 2011 2013 Antiviral Res 97(2): 206-210. 
PubMed link
DOI:10.1016/j.antiviral.2012.12.016
Hurt AC, Leang SK, Tiedemann K, Butler J, Mechinaud F, Kelso A, Downie P and Barr IG Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient 2013 Influenza Other Respi Viruses. 
PubMed link
DOI:10.1111/irv.12108
Short KR, Habets MN, Payne J, Reading PC, Diavatopoulos DA and Wijburg OL Influenza A virus induced bacterial otitis media is independent of virus tropism for alpha2,6-linked sialic acid 2013 Virol J 10: 128. 
PubMed link
DOI:10.1186/1743-422X-10-128
Jegaskanda S, Job ER, Kramski M, Laurie K, Isitman G, de Rose R, Winnall WR, Stratov I, Brooks AG, Reading PC and Kent SJ Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies 2013 J Immunol 190(4): 1837-1848. 
PubMed link
DOI:10.4049/jimmunol.1201574
Job ER, Deng YM, Barfod KK, Tate MD, Caldwell N, Reddiex S, Maurer-Stroh S, Brooks AG and Reading PC Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses 2013 J Immunol 190(5): 2169-2177. 
PubMed link
DOI:10.4049/jimmunol.1202433
Short KR, Reading PC, Brown LE, Pedersen J, Gilbertson B, Job ER, Edenborough KM, Habets MN, Zomer A, Hermans PW, Diavatopoulos DA and Wijburg OL Influenza-induced inflammation drives pneumococcal otitis media 2013 Infect Immun 81(3): 645-652. 
PubMed link
DOI:10.1128/IAI.01278-12
Rockman S, Brown LE, Barr IG, Gilbertson B, Lowther S, Kachurin A, Kachurina O, Klippel J, Bodle J, Pearse M and Middleton D Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine 2013 J Virol 87(6): 3053-3061. 
PubMed link
DOI:10.1128/JVI.02434-12
Reece JC, Alcantara S, Gooneratne S, Jegaskanda S, Amaresena T, Fernandez CS, Laurie K, Hurt A, O'Connor SL, Harris M, Petravic J, Martyushev A, Grimm A, Davenport MP, Stambas J, De Rose R and Kent SJ Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques 2013 J Virol 87(8): 4146-4160. 
PubMed link
DOI:10.1128/JVI.02645-12
Guarnaccia T, Carolan LA, Maurer-Stroh S, Lee RT, Job E, Reading PC, Petrie S, McCaw JM, McVernon J, Hurt AC, Kelso A, Mosse J, Barr IG and Laurie KL Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in a ferret model 2013 PLoS Pathog 9(5): e1003354. 
PubMed link
DOI:10.1371/journal.ppat.1003354
WHO (2013). China—WHO joint mission on human infection with avian influenza A(H7N9) virus 18 – 24 April 2013, Mission Report 2013 WHO. Available online
Petrie SM, Guarnaccia T, Laurie KL, Hurt AC, McVernon J and McCaw JM Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load 2013 PLoS One 8(5): e64098. 
PubMed link
DOI:10.1371/journal.pone.0064098
Barr IG and Hurt AC Double dose oseltamivir for severe influenza--does it help? 2013 BMJ 346: f3449. 
PubMed link
Hsu AC, Parsons K, Barr I, Lowther S, Middleton D, Hansbro PM and Wark PA Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection 2012 PLoS One 7(3): e32947. 
PubMed link
DOI:10.1371/journal.pone.0032947
Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Smith D, Tashiro M, Xu X, Webby R, Wang D, Ye Z, Yuelong S, Zhang W and Cox N WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011 2012 Vaccine 30(45): 6461-6471. 
PubMed link
DOI:S0264-410X(12)01135-8 [pii] 10.1016/j.vaccine.2012.07.089
Chin R, Earnest-Silviera L, Gordon CL, Olsen K, Barr I, Brown LE, Jackson DC and Torresi J Impaired dendritic cell maturation in response to pandemic H1N109 influenza virus 2013 J Clin Virol 56(3): 310-315. 
PubMed link
DOI:10.1016/j.jcv.2012.11.009
Bodle J, Verity EE, Ong C, Vandenberg K, Shaw R, Barr IG and Rockman S Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion 2013 Influenza Other Respi Viruses 7(2): 191-200. 
PubMed link
DOI:10.1111/j.1750-2659.2012.00375.x
Laurie KL, Huston P, Riley S, Katz JM, Willison DJ, Tam JS, Mounts AW, Hoschler K, Miller E, Vandemaele K, Broberg E, Van Kerkhove MD and Nicoll A Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting 2013 Influenza Other Respi Viruses 7(2): 211-224. 
PubMed link
DOI:10.1111/j.1750-2659.2012.0370a.x
Soh SE, Cook AR, Chen MI, Lee VJ, Cutter JL, Chow VT, Tee NW, Lin RT, Lim WY, Barr IG, Lin C, Phoon MC, Ang LW, Sethi SK, Chong CY, Goh LG, Goh DL, Tambyah PA, Thoon KC, Leo YS and Saw SM Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases - evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore 2012 BMC Infect Dis 12: 336. 
PubMed link
Barr IG and Jelley LL The coming era of quadrivalent human influenza vaccines: who will benefit? 2012 Drugs 72(17): 2177-2185. 
PubMed link
DOI:10.2165/11641110-000000000-00000
Hurt AC, Butler J, Kelso A and Barr IG Influenza antivirals and resistance: the next 10 years? 2012 Expert Rev Anti Infect Ther 10(11): 1221-1223. 
PubMed link
DOI:10.1586/eri.12.125
Short KR, Brooks AG, Reading PC and Londrigan SL The fate of influenza A virus after infection of human macrophages and dendritic cells 2012 J Gen Virol 93(Pt 11): 2315-2325. 
PubMed link
DOI: 10.1099/vir.0.045021-0
Inforzato A, Reading PC, Barbati E, Bottazzi B, Garlanda C and Mantovani A The "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation 2013 Front Immunol 3: 407. 
PubMed link
DOI:10.3389/fimmu.2012.00407
Kelso A and Reading PC Influenza in the Pacific 2010 PNG Med J 53: 180-190. 
Available online
Meijer A, Jonges M, van Beek P, Swaan C, Osterhaus A, Daniels R, Hurt A and Koopmans M Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012 2012 Euro Surveill 17(36). 
PubMed link
Hurt AC and Barr IG Rapid diagnostic test kits for influenza 2006 Microbiol Aus 27(2): 61-63.  PubMed link
Short KR, Reading PC, Wang N, Diavatopoulos DA and Wijburg OL Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae 2012 MBio 3(5). 
PubMed link
DOI: 10.1128/mBio.00255-12
Kelso A and Hurt AC The ongoing battle against influenza: drug-resistant influenza viruses: why fitness matters 2012 Nat Med 18(10): 1470-1471. 
PubMed link
DOI: 10.1038/nm.2954
Wang B, Taylor J, Ratnamohan M, McPhie K, Kesson A, Dixit R, Booy R, Hurt A, Saksena N and Dwyer D Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011 2012 Euro Surveill 17(27): pii: 20210. 
PubMed link
WHO/OIE/FAO H5N1 Working Group Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature 2012 Influenza Other Respi Viruses 6(1): 1-5. 
PubMed link
DOI:10.1111/j.1750-2659.2011.00298.x
Londrigan SL, Tate MD, Brooks AG and Reading PC Cell-surface receptors on macrophages and dendritic cells for attachment and entry of influenza virus 2012 J Leukoc Biol 92(1): 97-106. 
PubMed link
DOI: 10.1189/jlb.1011492
Mulley WR, Visvanathan K, Hurt AC, Brown FG, Polkinghorne KR, Mastorakos T, Lewicki MC, Stuart RL, Tan SJ, Chean R, Kerr PG and Kanellis J Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination 2012 Kidney Int 82(2): 212-219. 
PubMed link
DOI:10.1038/ki.2012.106
Rockman S, Middleton DJ, Pearse MJ, Barr IG, Lowther S and Brown LE Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines 2012 Vaccine 30(24): 3618-3623. 
PubMed link
DOI:S0264-410X(12)00433-1 [pii] 10.1016/j.vaccine.2012.03.043
Kelso A CD4+ T cells limit the damage in influenza 2012 Nat Med 18(2): 200-202. 
PubMed link
DOI:10.1038/nm.2654
Members of the Western Pacific Region Global Influenza Surveillance and Response System Epidemiological and virological characteristics of influenza in the Western pacific region of the world health organization, 2006-2010 2012 PLoS One 7(5): e37568. 
PubMed link
DOI:10.1371/journal.pone.0037568
Tate MD, Brooks AG, Reading PC and Mintern JD Neutrophils sustain effective CD8+ T-cell responses in the respiratory tract following influenza infection 2012 Immunol Cell Biol 90(2): 197-205. 
PubMed link
DOI: 10.1038/icb.2011.26
Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D and Barr IG Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia 2012 J Infect Dis 206(2): 148-157. 
PubMed link
DOI: 10.1093/infdis/jis337
Hurt AC, Okomo-Adhiambo M and Gubareva LV The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors 2012 Methods Mol Biol 865: 115-125. 
PubMed link
DOI:10.1007/978-1-61779-621-0_7
Okomo-Adhiambo M, Hurt AC and Gubareva LV The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors 2012 Methods Mol Biol 865: 95-113. 
PubMed link
DOI:10.1007/978-1-61779-621-0_6
Verity EE, Camuglia S, Agius CT, Ong C, Shaw R, Barr I, Middleton D and Rockman S Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA 2012 Influenza Other Respi Viruses 6(2): 101-109. 
PubMed link
DOI:10.1111/j.1750-2659.2011.00273.x
Ng WC, Tate MD, Brooks AG and Reading PC Soluble host defense lectins in innate immunity to influenza virus 2012 J Biomed Biotechnol 2012: 732191. 
PubMed link
DOI:10.1155/2012/732191
WHO Writing Group, Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M and Zhang W Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010 2012 Influenza Other Respi Viruses 6(2): 142-152, e141-145. 
PubMed link
DOI:10.1111/j.1750-2659.2011.00277.x
Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, Hayden FG, Hui DS, Hungnes O, Lackenby A, Lim W, Meijer A, Penn C, Tashiro M, Uyeki TM and Zambon M Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives 2012 Lancet Infect Dis 12(3): 240-248. 
PubMed link
DOI: 10.1016/S1473-3099(11)70318-8
Deng YM, Iannello P, Smith I, Watson J, Barr IG, Daniels P, Komadina N, Harrower B and Wong FY Transmission of influenza A(H1N1) 2009 pandemic viruses in Australian swine 2012 Influenza Other Respi Viruses 6(3): e42-47. 
PubMed link
DOI:10.1111/j.1750-2659.2012.00337.x
Arzey GG, Kirkland PD, Arzey KE, Frost M, Maywood P, Conaty S, Hurt AC, Deng YM, Iannello P, Barr I, Dwyer DE, Ratnamohan M, McPhie K and Selleck P Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia 2012 Emerg Infect Dis 18(5): 814-816. 
PubMed link
DOI:10.3201/eid1805.111852
Hurt AC, Leang SK, Speers DJ, Barr IG and Maurer-Stroh S Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses 2012 Emerg Infect Dis 18(1): 109-112. 
PubMed link
DOI:10.3201/eid1801.111079
Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Gehrig N and Kelso A Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza 2011 N Engl J Med 365(26): 2541-2542. 
PubMed link
DOI:10.1056/NEJMc1111078
Trauer JM, Laurie KL, McDonnell J, Kelso A and Markey PG Differential effects of pandemic (H1N1) 2009 on remote and indigenous groups, northern territory, Australia, 2009 2011 Emerg Infect Dis 17(9): 1615-1623. 
PubMed link
DOI:10.3201/eid1709.101196
Haller W, Buttery J, Laurie K, Beyerle K, Hardikar W and Alex G Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients 2011 Liver Transpl 17(8): 914-920. 
PubMed link
DOI:10.1002/lt.22283
Kelly H, Peck HA, Laurie KL, Wu P, Nishiura H and Cowling BJ The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination 2011 PLoS One 6(8): e21828. 
PubMed link
DOI:10.1371/journal.pone.0021828
Short KR, Diavatopoulos DA, Thornton R, Pedersen J, Strugnell RA, Wise AK, Reading PC and Wijburg OL Influenza virus induces bacterial and nonbacterial otitis media 2011 J Infect Dis 204(12): 1857-1865. 
PubMed link
DOI:10.1093/infdis/jir618
Crispe E, Finlaison DS, Hurt AC and Kirkland PDInfection of dogs with equine influenza virus: evidence for transmission from horses during the Australian outbreak 2011 Aust Vet J 89 Suppl 1: 27-28. 
PubMed link
DOI:10.1111/j.1751-0813.2011.00734.x
Deng YM, Caldwell N and Barr IGRapid detection and subtyping of human influenza A viruses and reassortants by pyrosequencing 2011 PLoS One 6(8): e23400. 
PubMed link
DOI:10.1371/journal.pone.0023400
Eisen DP, Marshall C, Dean MM, Sasadeusz J, Richards M, Buising K, Cheng A, Johnson PD, Barr IG and McBryde ESNo association between mannose-binding lectin deficiency and H1N1 2009 infection observed during the first season of this novel pandemic influenza virus 2011 Hum Immunol 72(11): 1091-1094. 
PubMed link
DOI:10.1016/j.humimm.2011.08.014
Hurt AC, Lee RT, Leang SK, Cui L, Deng YM, Phuah SP, Caldwell N, Freeman K, Komadina N, Smith D, Speers D, Kelso A, Lin RT, Maurer-Stroh S and Barr IGIncreased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation 2011 Euro Surveill 16(23). 
PubMed link
Lee VJ, Chen MI, Yap J, Ong J, Lim WY, Lin RT, Barr I, Ong JB, Mak TM, Goh LG, Leo YS, Kelly PM and Cook ARComparability of different methods for estimating influenza infection rates over a single epidemic wave 2011 Am J Epidemiol 174(4): 468-478. 
PubMed link
DOI:10.1093/aje/kwr113
Lim WY, Chen CH, Ma Y, Chen MI, Lee VJ, Cook AR, Tan LW, Flores Tabo N, Jr., Barr I, Cui L, Lin RT, Leo YS and Chia KSRisk factors for pandemic (H1N1) 2009 seroconversion among adults, Singapore, 2009 2011 Emerg Infect Dis 17(8): 1455-1462. 
PubMed link
DOI:10.3201/eid1708.101270
Marshall C, Kelso A, McBryde E, Barr IG, Eisen DP, Sasadeusz J, Buising K, Cheng AC, Johnson P and Richards MPandemic (H1N1) 2009 risk for frontline health care workers 2011 Emerg Infect Dis 17(6): 1000-1006. 
PubMed link
DOI:10.3201/eid/1706.101030
Tate MD, Brooks AG and Reading PCSpecific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice 2011 J Immunol 187(4): 1884-1894. 
PubMed link
DOI: 10.4049/jimmunol.1100295
Teo J, Di Pietro P, San Biagio F, Capozzoli M, Deng YM, Barr I, Caldwell N, Ong KL, Sato M, Tan R and Lin RVereFlu: an integrated multiplex RT-PCR and microarray assay for rapid detection and identification of human influenza A and B viruses using lab-on-chip technology 2011 Arch Virol 156(8): 1371-1378. 
PubMed link
DOI:10.1007/s00705-011-0999-7
Tong SY, Dakh F, Hurt AC, Deng YM, Freeman K, Fagan PK, Barr IG and Giffard PMRapid detection of the H275Y oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting 2011 PLoS One 6(6): e21446. 
PubMed link
DOI:10.1371/journal.pone.0021446
McCaw JM, Arinaminpathy N, Hurt AC, McVernon J and McLean ARA mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal model 2011 PLoS Comput Biol 7(4): e1002026. 
PubMed link
DOI:10.1371/journal.pcbi.1002026
Brown L, Cobbin J, Middleton D, Barr I, Zeng W and Jackson DUniversal vaccination: is this premature with current vaccine approaches? 2011 Influenza Other Respi Viruses 5(Suppl. 1): 2-53.  Online link
DOI: 10.1111/j.1750-2659.2011.00208.x
Buch J, Roomp K, Bach G, Steinbruck L, Beer M, Gregory V, Komadina N, Lan Y, Monne I, Smith C, Fujisaki S, Bogner P and Lengauer LGISAID - a global initiative on sharing all influenza data 2011 Influenza Other Respi Viruses 5(Suppl. 1): 419.  Online link
DOI: 10.1111/j.1750-2659.2011.00209.x
McVernon J, Laurie K, Nolan T, Owen R, Irving D, Capper H, Hyland C, Faddy H, Carolan L, Barr I and Kelso ASeroprevalence of antibody to influenza A(H1N1)2009 in Australian blood donors - before and after the 2009, influenza season, and prior to the 2010 Southern Hemisphere winter 2011 Influenza Other Respi Viruses 5(Suppl. 1): 175-178.  Online link
DOI: 10.1111/j.1750-2659.2011.00209.x
Peck H, Dodin J, Baas C, Shaw R, Lenz-Bauer C, Trusheim H, Roth B, Blayer S, Tsai T and Barr IEvaluation of growth, genetic, and antigenic characteristics of pandemic H1N1 viruses isolated and passaged in qualified MDCK suspension cells (MDCK33016PF) and embryonated hen eggs 2011 Influenza Other Respi Viruses 5(Suppl. 1): 328-394.  Online link
DOI: 10.1111/j.1750-2659.2011.00209.x
Roth B, Peck H, Schwarz K, Dodin J, Horn V, Trusheim H, Blayer S, Tsai T and Barr ICo-infecting viruses in pandemic H1N1 and seasonal influenza positive human respiratory samples 2011 Influenza Other Respi Viruses 5(Suppl. 1): 416-424.  Online link
DOI: 10.1111/j.1750-2659.2011.00209.x
Barr I and Selleck PInfluenza - our constant companion 2011 Microbiol Aus 32(1): 2-3.  Online link
Dowse GK and Barr IWhat serosurveillance studies tell us about the 2009 influenza pandemic 2011 Microbiol Aus 32(1): 18-21.  Online link
Hurt AAntiviral drug resistance in seasonal and pandemic influenza 2011 Microbiol Aus 32(1): 26-28.  Online link
Valkenburg SA, Laurie K, Kelso A, Turner SJ, Doherty PC and Kedzierska KT-cell immunity against the A(H1N1) 2009 pandemic virus 2011 Microbiol Aus 32(1): 22-25.  Online link
Wong FY and Deng YPandemic H1N1 2009 influenza in pigs in Australia 2011 Microbiol Aus 32(1): 39-41.  Online link
Tate MD, Schilter HC, Brooks AG and Reading PC Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus 2011 Viral Immunol 24(2): 77-88. 
PubMed link
DOI: 10.1089/vim.2010.0118
Tate MD, Ioannidis LJ, Croker B, Brown LE, Brooks AG and Reading PCThe role of neutrophils during mild and severe influenza virus infections of mice 2011

PLoS One 6(3): e17618. 
PubMed link
DOI:10.1371/journal.pone.0017618

Tate MD, Brooks AG and Reading PCReceptor specificity of the influenza virus hemagglutinin modulates sensitivity to soluble collectins of the innate immune system and virulence in mice 2011 Virology. 
PubMed link
DOI: 10.1016/j.virol.2011.01.035
Rosewell A, Dagina R, Murhekar M, Ropa B, Posanai E, Dutta S, Barr I, Mola G, Zwi A and Macintyre CRConcurrent influenza and shigellosis outbreaks, Papua New Guinea, 2009 2011 Emerg Infect Dis 17(4): 756-758. 
PubMed link
DOI: 10.3201/eid1706.101021
Deng YM, Caldwell N, Hurt A, Shaw T, Kelso A, Chidlow G, Williams S, Smith D and Barr IA comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses 2011 Antiviral Res. 
PubMed link
DOI: 10.1016/j.antiviral.2011.02.014
Kelso AInfluenza 2011 in "Health". Sykes H (ed.), Future Leaders, Australia, p.45-64.
Tate MD, Job ER, Brooks AG and Reading PCGlycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice 2011 Virology. 
PubMed link
DOI: 10.1016/j.virol.2011.01.036
Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, Baker MG, Beasley R, Reid S, Roberts S, Hope V and 2009 H1N1 Serosurvey Investigation Team Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic 2010 PLoS One 5(10): e13211. 
PubMed link
DOI: 10.1371/journal.pone.0013211
Hurt A, Deng Y, Ernest J, Caldwell N, Leang L, Iannello P, Komadina N, Shaw R, Smith D, Dwyer D, Tramontana A, Lin R, Freeman K, Kelso A and Barr IOseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1)2009 pandemic in the Asia-Pacific region, March 2009 to March 2010 2011 Euro Surveill 16(3). 
PubMed link
[pii] 19770
Dowse GK, Smith DW, Kelly H, Barr I, Laurie KL, Jones AR, Keil AD and Effler PIncidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study 2011 Med J Aust 194(2): 68-72. 
PubMed link
McVernon J, Nolan T, Laurie K, Barr I, Kelso A, Hyland C, Faddy H, Capper H and Irving DNational Pandemic (H1N1) 2009 (pH1N1) Serosurveillance Study. Assessment of immunity to pH1N1 among healthy Blood Service blood donors: Specimens collected November 2010. Timepoint 3 2010 Report to the Office of Health Protection, Australian Government Department of Health and Ageing
Londrigan SL, Turville SG, Tate MD, Deng YM, Brooks AG and Reading PCN-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN 2010 J Virol. 
PubMed link
Mardani J, Calder L, Laurie K, Barr I, Kelso A and Jones N Limited novel influenza A (H1N1) 09 infection in travelling high-school tour group 2011 Influenza Other Respi Viruses 5(1): 47-51. 
PubMed link
DOI: 10.1111/j.1750-2659.2010.00169.x
McVernon J, Laurie K, Barr I, Kelso A, Skeljo M and Nolan T Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study 2011 Influenza Other Respi Viruses 5(1): 7-11. 
PubMed link
10.1111/j.1750-2659.2010.00172.x
NNDSS Annual Report Writing Group: Newman L, Stirzaker S, Knuckey D, Robinson K, Hood J, Knope K, Fitzsimmons G, Barker S, Martin N, Siripol S, Gajanayake I, Kaczmarek M, Barr I, Hii A, Foxwell R, Owen R, Liu C, Wright P, Sanders L, Barry C and Ormond J Australia's notifiable disease status, 2008: annual report of the National Notifiable Diseases Surveillance System 2010 Commun Dis Intell 34(3): 157-224. 
PubMed link
Kelly H, Barry S, Laurie K and Mercer G Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection 2010 Euro Surveill 15(47). 
PubMed link
[pii] 19722
Baker MG, Thornley CN, Mills C, Roberts S, Perera S, Peters J, Kelso A, Barr I and Wilson N Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study 2010 BMJ 340: c2424. 
PubMed link
10.1136/bmj.c2424
Barr IG, Cui L, Komadina N, Lee RT, Lin RT, Deng Y, Caldwell N, Shaw R and Maurer-Stroh S A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore 2010 Euro Surveill 15(42). 
PubMed link
[pii] 19692
Barr IG, McCauley J, Cox N, Daniels R, Engelhardt OG, Fukuda K, Grohmann G, Hay A, Kelso A, Klimov A, Odagiri T, Smith D, Russell C, Tashiro M, Webby R, Wood J, Ye Z and Zhang W Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season 2010 Vaccine 28(5): 1156-1167. 
PubMed link
10.1016/j.vaccine.2009.11.043
Blyth CC, Foo H, van Hal SJ, Hurt AC, Barr IG, McPhie K, Armstrong PK, Rawlinson WD, Sheppeard V, Conaty S, Staff M and Dwyer DE; World Youth Day 2008 Influenza Study Group Influenza outbreaks during World Youth Day 2008 mass gathering 2010 Emerg Infect Dis 16(5): 809-815. 
PubMed link
DOI: 10.3201/eid1605.091136
Blyth CC, Kelso A, McPhie KA, Ratnamohan VM, Catton M, Druce JD, Smith DW, Williams SH, Huang QS, Lopez L, Schoub BD, Venter M and Dwyer DE The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009 2010 Euro Surveill 15(31). 
PubMed link
[pii] 19631
Chen MI, Barr IG, Koh GC, Lee VJ, Lee CP, Shaw R, Lin C, Yap J, Cook AR, Tan BH, Loh JP, Barkham T, Chow VT, Lin RT and Leo YS Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study 2010 PLoS One 5(8): e12474. 
PubMed link
DOI: 10.1371/journal.pone.0012474
Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, Koh GC, Yap J, Cui L, Cook AR, Laurie K, Tan LW, Tan BH, Loh J, Shaw R, Durrant C, Chow VT, Kelso A, Chia KS and Leo YS 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore 2010 JAMA 303(14): 1383-1391. 
PubMed link
DOI: 10.1001/jama.2010.404
Chidlow GR, Harnett GB, Williams SH, Tempone SS, Speers DJ, Hurt AC, Deng YM and Smith DW The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay 2010 J Virol Methods 169(1): 47-51. 
PubMed link
DOI: 10.1016/j.jviromet.2010.06.014
Gras S, Kedzierski L, Valkenburg SA, Laurie K, Liu YC, Denholm JT, Richards MJ, Rimmelzwaan GF, Kelso A, Doherty PC, Turner SJ, Rossjohn J and Kedzierska K Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses 2010 Proc Natl Acad Sci U S A 107(28): 12599-12604. 
PubMed link
DOI: 10.1073/pnas.1007270107
Grills N, Piers LS, Barr I, Vaughan LM, Lester R, Magliano DJ, Shaw JE and Carnie JA A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009 2010 Aust N Z J Public Health 34(3): 228-231. 
PubMed link
DOI: 10.1111/j.1753-6405.2010.00518.x.
Hansbro PM, Warner S, Tracey JP, Arzey KE, Selleck P, O'Riley K, Beckett EL, Bunn C, Kirkland PD, Vijaykrishna D, Olsen B and Hurt AC Surveillance and analysis of avian influenza viruses, Australia 2010 Emerg Infect Dis 16(12): 1896-1904. 
PubMed link
DOI: 10.3201/eid1612.100776
Hsu AC, Barr I, Hansbro PM and Wark PA Human influenza is more effective than avian influenza at antiviral suppression in airway cells 2010 Am J Respir Cell Mol Biol. 
PubMed link
DOI: 10.1165/rcmb.2010-0157OC
Hurt AC, Lowther S, Middleton D and Barr IG Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model 2010 Antiviral Res 87(3): 361-366. 
PubMed link
DOI: 10.1016/j.antiviral.2010.06.009
Hurt AC, Nor'e SS, McCaw JM, Fryer HR, Mosse J, McLean AR and Barr IG Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model 2010 J Virol 84(18): 9427-9438. 
PubMed link
DOI: 10.1128/JVI.00373-10
Job ER, Deng YM, Tate MD, Bottazzi B, Crouch EC, Dean MM, Mantovani A, Brooks AG and Reading PC Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies 2010 J Immunol 185(7): 4284-4291. 
PubMed link
DOI: 10.4049/jimmunol.1001613
Kaczmarek M, Owen R and Barr IG Annual report of the National Influenza Surveillance Scheme, 2008 2010 Commun Dis Intell 34(1): 8-22. 
PubMed link
Kelly H and Barr I Large trials confirm immunogenicity of H1N1 vaccines 2010 Lancet 375(9708): 6-9. 
PubMed link
DOI: 10.1016/S0140-6736(09)62132-2
Kirkland PD, Finlaison DS, Crispe E and Hurt AC Influenza virus transmission from horses to dogs, Australia 2010 Emerg Infect Dis 16(4): 699-702. 
PubMed link
DOI: 10.3201/eid1604.091489
Lam WY, Leung TF, Lee N, Cheung JL, Yeung AC, Ho YI, Chan RC, Fung KS, Barr IG, Hui DS, Sung JJ and Chan PK Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus 2010 J Med Virol 82(4): 675-683. 
PubMed link
DOI: 10.1002/jmv.21725
Laurie KL, Carolan LA, Middleton D, Lowther S, Kelso A and Barr IG Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model 2010 J Infect Dis 202(7): 1011-1020. 
PubMed link
DOI: 10.1086/656188
Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, Barr I, Kelso A, Tan BH, Loh JP, Lin R, Cui L, Kelly PM, Leo YS, Chia KS, Kang WL, Tambyah PA and Seet B Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study 2010 J Infect Dis 202(9): 1319-1326. 
PubMed link
DOI: 10.1086/656480
Lee VJ, Yap J, Tay JK, Barr I, Gao Q, Ho HJ, Tan BH, Kelly PM, Tambyah PA, Kelso A and Chen MI Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009 2010 BMC Infect Dis 10: 164. 
PubMed link
DOI: 10.1186/1471-2334-10-164
McVernon J, Laurie K, Nolan T, Owen R, Irving D, Capper H, Hyland C, Faddy H, Carolan L, Barr I and Kelso A Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009 2010 Euro Surveill 15(40). 
PubMed link
[pii] 19678
Reading PC, Whitney PG, Pickett DL, Tate MD and Brooks AG Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice 2010 Immunol Cell Biol 88(6): 641-650. 
PubMed link
DOI: 10.1038/icb.2010.11
Speers DJ, Williams SH, Pinder M, Moody HR, Hurt AC and Smith DW Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case 2010 Med J Aust 192(3): 166-168. 
PubMed link
Tang JW, Lai FY, Nymadawa P, Deng YM, Ratnamohan M, Petric M, Loh TP, Tee NW, Dwyer DE, Barr IG and Wong FY Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countries 2010 J Med Virol 82(11): 1958-1965. 
PubMed link
DOI: 10.1002/jmv.21892
Tang JW, Tambyah PA, Wilder-Smith A, Puong KY, Shaw R, Barr IG and Chan KP Cross-reactive antibodies to pandemic (H1N1) 2009 virus, Singapore 2010 Emerg Infect Dis 16(5): 874-876. 
PubMed link
DOI: 10.3201/eid1605.091678
Tate MD, Brooks AG and Reading PC Inhibition of lectin-mediated innate host defences in vivo modulates disease severity during influenza virus infection 2011 Immunol Cell Biol 89(3): 482-491.  
PubMed link
DOI: 10.1038/icb.2010.113
Tate MD, Brooks AG and Reading PC Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus 2010 Microbes Infect. 
PubMed link
DOI: 10.1016/j.micinf.2010.10.004
Tate MD, Pickett DL, van Rooijen N, Brooks AG and Reading PC Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice 2010 J Virol 84(15): 7569-7580. 
PubMed link
DOI: 10.1128/JVI.00291-10
Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, Harper JM, Thursky K, Worth LJ, Dwyer DE, Morrissey CO, Johnson PD, Buising KL, Harrison SJ, Seymour JF, Ferguson PE, Wang B, Denholm JT, Cheng AC and Slavin M Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia 2010 Emerg Infect Dis 16(7): 1068-1075. 
PubMed link
DOI: 10.3201/eid1607.091691
Turner SJ, Doherty PC and Kelso A Q&A: H1N1 pandemic influenza--what's new? 2010 BMC Biol 8: 130. 
PubMed link
DOI: 10.1186/1741-7007-8-130
Upham JP, Pickett D, Irimura T, Anders EM and Reading PC Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry 2010 J Virol 84(8): 3730-3737. 
PubMed link
DOI: 10.1128/JVI.02148-09
Bertozzi S, Kelso A, Tashiro M, Savy V, Farrar J, Osterholm M, Jameel S and Muller CP Pandemic flu: from the front lines. Interviewed by Declan Butler 2009 Nature 461(7260): 20-21. 
PubMed link
DOI: 10.1038/461020a
Brown LE and Kelso A Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes 2009 Immunol Cell Biol 87(4): 300-308. 
PubMed link
DOI: 10.1038/icb.2009.16
Chen J and Deng YM Influenza virus antigenic variation, host antibody production and new approach to control epidemics 2009 Virol J 6: 30. 
PubMed link
DOI: 10.1186/1743-422X-6-30
Dashper SG, Ang CS, Veith PD, Mitchell HL, Lo AW, Seers CA, Walsh KA, Slakeski N, Chen D, Lissel JP, Butler CA, O'Brien-Simpson NM, Barr IG and Reynolds EC Response of Porphyromonas gingivalis to heme limitation in continuous culture 2009 J Bacteriol 191(3): 1044-1055. 
PubMed link
DOI: 10.1128/JB.01270-08
Doherty PC, Brown LE, Kelso A and Thomas PG Immunity to avian influenza A viruses 2009 Rev Sci Tech 28(1): 175-185. 
PubMed link
Grant KA, Carville K, Fielding JE, Barr IG, Riddell MA, Tran T and Kelly HA High proportion of influenza B characterises the 2008 influenza season in Victoria 2009 Commun Dis Intell 33(3): 328-336. 
PubMed link
Grayson ML, Melvani S, Druce J, Barr IG, Ballard SA, Johnson PD, Mastorakos T and Birch C Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers 2009 Clin Infect Dis 48(3): 285-291. 
PubMed link
DOI: 10.1086/595845
Guillonneau C, Mintern JD, Hubert FX, Hurt AC, Besra GS, Porcelli S, Barr IG, Doherty PC, Godfrey DI and Turner SJ Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity 2009 Proc Natl Acad Sci U S A 106(9): 3330-3335. 
PubMed link
DOI: 10.1073/pnas.0813309106
Haynes L, Arzey E, Bell C, Buchanan N, Burgess G, Cronan V, Dickason C, Field H, Gibbs S, Hansbro P, Hollingsworth T, Hurt A, Kirkland P, McCracken H, O'Connor J, Tracey J, Wallner J, Warner S, Woods R and Bunn C Australian surveillance for avian influenza viruses in wild birds between July 2005 and June 2007 2009 Aust Vet J 87(7): 266-272. 
PubMed link
DOI: 10.1111/j.1751-0813.2009.00446.x
Hurt AC, Baas C, Deng YM, Roberts S, Kelso A and Barr IG Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses 2009 Influenza Other Respi Viruses 3(4): 171-176. 
PubMed link
DOI: 10.1111/j.1750-2659.2009.00086.x
Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D'Souza H, Komadina N, Shaw R, Kelso A and Barr IG Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa 2009 Antiviral Res 83(1): 90-93. 
PubMed link
DOI: 10.1016/j.antiviral.2009.03.003
Hurt AC, Holien JK and Barr IG In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses 2009 Antimicrob Agents Chemother 53(10): 4433-4440. 
PubMed link
DOI: 10.1128/AAC.00334-09
Hurt AC, Holien JK, Parker M, Kelso A and Barr IG Zanamivir-resistant influenza viruses with a novel neuraminidase mutation 2009 J Virol 83(20): 10366-10373. 
PubMed link
DOI: 10.1128/JVI.01200-09
Hurt AC, Holien JK, Parker MW and Barr IG Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses 2009 Drugs 69(18): 2523-2531. 
PubMed link
DOI: 10.2165/11531450-000000000-00000
Kay B, Prowse S, Baldwin K, Carapetis J, Horvath J, Kelso A, Mackenzie J and Sleigh A Epidemics in a changing world. 2009 Report of the Expert Working Group on Epidemics in a Changing World to the Prime Minister's Science, Engineering and Innovation Council  
Online link
Kelly H, Carville K, Grant K, Jacoby P, Tran T and Barr I Estimation of influenza vaccine effectiveness from routine surveillance data 2009 PLoS One 4(3): e5079. 
PubMed link
DOI: 10.1371/journal.pone.0005079
Kelso A Influenza 2009 Parliament of Victoria and Academy of Technological Sciences and Engineering, Presiding Officers' Science Series, Note No. 4, December 2009 Download PDF
La Gruta N, Kelso A, Brown LE, Chen W, Jackson DC and Turner SJ Role of CD8+ T-cell immunity in influenza infection: potential use in future vaccine development 2009 Expert Rev Respir Med 3(5): 523-537. 
PubMed link
DOI: 10.1586/ers.09.44
Middleton D, Rockman S, Pearse M, Barr I, Lowther S, Klippel J, Ryan D and Brown L Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization 2009 J Virol 83(15): 7770-7778. 
PubMed link
DOI: 10.1128/JVI.00241-09
Reading PC, Pickett DL, Tate MD, Whitney PG, Job ER and Brooks AG Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice 2009 Respir Res 10: 117. 
PubMed link
DOI: 10.1186/1465-9921-10-117
Sexton A, De Rose R, Reece JC, Alcantara S, Loh L, Moffat JM, Laurie K, Hurt A, Doherty PC, Turner SJ, Kent SJ and Stambas J Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques 2009 J Virol 83(15): 7619-7628. 
PubMed link
DOI: 10.1128/JVI.00470-09
Steain MC, Dwyer DE, Hurt AC, Kol C, Saksena NK, Cunningham AL and Wang B Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification 2009 Antiviral Res 84(3): 242-248. 
PubMed link
DOI: 10.1016/j.antiviral.2009.09.010
Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG and Reading PC Neutrophils ameliorate lung injury and the development of severe disease during influenza infection 2009 J Immunol 183(11): 7441-7450. 
PubMed link
DOI: 10.4049/jimmunol.0902497
Turner SJ, Brown LE, Doherty PC and Kelso A Q&A: What have we found out about the influenza A (H1N1) 2009 pandemic virus? 2009 J Biol 8(8): 69. 
PubMed link
DOI: 10.1186/jbiol179
Barr IG, Deng YM, Iannello P, Hurt AC and Komadina N Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries 2008 Antiviral Res 80(2): 200-205. 
PubMed link
DOI: 10.1016/j.antiviral.2008.06.008
Doherty PC and Kelso A Toward a broadly protective influenza vaccine 2008 J Clin Invest 118(10): 3273-3275. 
PubMed link
Goy K, Von Bibra S, Lewis J, Laurie K, Barr I, Anderson D, Hellard M and Ffrench R Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza 2008 Influenza Other Respi Viruses 2(4): 115-125. 
PubMed link
DOI: 10.1111/j.1750-2659.2008.00046.x
Hurt AC and Barr IG Influenza viruses with reduced sensitivity to the neuraminidase inhibitor drugs in untreated young children 2008 Commun Dis Intell 32(1): 57-62. 
PubMed link
Manton M and Kelso A Equine influenza (horse flu) 2008 Parliament of Victoria and Academy of Technological Sciences and Engineering, Presiding Officers' Science Series, Note No. 1, February 2008 Download PDF
Miller ER, Fielding JE, Grant KA, Barr IG, Papadakis G and Kelly HA Higher than expected seasonal influenza activity in Victoria, 2007 2008 Commun Dis Intell 32(1): 63-70. 
PubMed link
Oh DY, Barr IG, Mosse JA and Laurie KL MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells 2008 J Clin Microbiol 46(7): 2189-2194. 
PubMed link
DOI: 10.1128/JCM.00398-08
Owen R, Barr IG, Pengilley A, Liu C, Paterson B and Kaczmarek M Annual report of the National Influenza Surveillance Scheme, 2007 2008 Commun Dis Intell 32(2): 208-226. 
PubMed link
Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA and Smith DJ The global circulation of seasonal influenza A (H3N2) viruses 2008 Science 320(5874): 340-346. 
PubMed link
DOI: 10.1126/science.1154137
Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA and Smith DJ Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses 2008 Vaccine 26 Suppl 4: D31-34. 
PubMed link
Stelzer-Braid S, Wong B, Robertson P, Lynch GW, Laurie K, Shaw R, Barr I, Selleck PW, Baleriola C, Escott R, Katsoulotos G and Rawlinson WD A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies 2008 J Clin Virol 43(2): 241-243. 
PubMed link
DOI: 10.1016/j.jcv.2008.06.012
Yun NE, Linde NS, Zacks MA, Barr IG, Hurt AC, Smith JN, Dziuba N, Holbrook MR, Zhang L, Kilpatrick JM, Arnold CS and Paessler S Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1) 2008 Virology 374(1): 198-209. 
PubMed link
DOI: 10.1016/j.virol.2007.12.029
Barr IG, Hurt AC, Deed N, Iannello P, Tomasov C and Komadina N The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006 2007 Antiviral Res 75(2): 173-176. 
PubMed link
Barr IG, Hurt AC, Iannello P, Tomasov C, Deed N and Komadina N Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005 2007 Antiviral Res 73(2): 112-117. 
PubMed link
Gust I Some issues raised by the current influenza H5N1 outbreak 2007 Biologicals 35(1): 1-3. 
PubMed link
Ho HT, Hurt AC, Mosse J and Barr I Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues 2007 Antiviral Res 76(3): 263-266. 
PubMed link
Hurt AC, Alexander R, Hibbert J, Deed N and Barr IG Performance of six influenza rapid tests in detecting human influenza in clinical specimens 2007 J Clin Virol 39(2): 132-135. 
PubMed link
Hurt AC, Selleck P, Komadina N, Shaw R, Brown L and Barr IG Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes 2007 Antiviral Res 73(3): 228-231. 
PubMed link
Jayawardena S, Cheung CY, Barr I, Chan KH, Chen H, Guan Y, Peiris JS and Poon LL Loop-mediated isothermal amplification for influenza A (H5N1) virus 2007 Emerg Infect Dis 13(6): 899-901. 
PubMed link
Komadina N, Roque V, Thawatsupha P, Rimando-Magalong J, Waicharoen S, Bomasang E, Sawanpanyalert P, Rivera M, Iannello P, Hurt AC and Barr IG Genetic analysis of two influenza A (H1) swine viruses isolated from humans in Thailand and the Philippines 2007 Virus Genes 35(2): 161-165. 
PubMed link
Li OT, Barr I, Leung CY, Chen H, Guan Y, Peiris JS and Poon LL Reliable universal RT-PCR assays for studying influenza polymerase subunit gene sequences from all 16 haemagglutinin subtypes 2007 J Virol Methods 142(1-2): 218-222. 
PubMed link
O'Brien K and Barr IG Annual report of the National Influenza Surveillance Scheme, 2006 2007 Commun Dis Intell 31(2): 167-179. 
PubMed link
Ayob A, Selviendran N, Hampson AW, Barr IG, Kumarasamy V and Chua KB Outbreak of influenza amongst residential school students in Malaysia 2006 Med J Malaysia 61(2): 168-172. 
PubMed link
Barr IG, Komadina N, Durrant C, Sjogren H, Hurt AC and Shaw RP Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000 2006 Commun Dis Intell 30(3): 350-357. 
PubMed link
Barr IG, McCaig M, Durrant C and Shaw R The rapid identification of human influenza neuraminidase N1 and N2 subtypes by ELISA 2006 Vaccine 24(44-46): 6675-6678. 
PubMed link
Cook IF, Barr I, Hartel G, Pond D and Hampson AW Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults 2006 Vaccine 24(13): 2395-2402. 
PubMed link
Dwyer DE, Smith DW, Catton MG and Barr IG Laboratory diagnosis of human seasonal and pandemic influenza virus infection 2006 Med J Aust 185(10 Suppl): S48-53. 
PubMed link
Firestone SM, Barr IG, Roche PW and Walker JC Annual report of the National Influenza Surveillance Scheme, 2005 2006 Commun Dis Intell 30(2): 189-200. 
PubMed link
Haaheim LR, Tomasov CC, Barr IG, Hampson AW and Komadina N Identification of genetic diversity by cultivating influenza A(H3N2) virus in vitro in the presence of post-infection sera from small children 2006 Vaccine 24(44-46): 6708-6711. 
PubMed link
Hurt AC, Hansbro PM, Selleck P, Olsen B, Minton C, Hampson AW and Barr IG Isolation of avian influenza viruses from two different transhemispheric migratory shorebird species in Australia 2006 Arch Virol 151(11): 2301-2309. 
PubMed link
Hurt AC, Ho HT and Barr I Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors 2006 Expert Rev Anti Infect Ther 4(5): 795-805. 
PubMed link
Hurt AC, Iannello P, Jachno K, Komadina N, Hampson AW, Barr IG and McKimm-Breschkin JL Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient 2006 Antimicrob Agents Chemother 50(5): 1872-1874. 
PubMed link
Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG and Zambon M Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use 2006 Antimicrob Agents Chemother 50(7): 2395-2402. 
PubMed link
Ng LF, Barr I, Nguyen T, Noor SM, Tan RS, Agathe LV, Gupta S, Khalil H, To TL, Hassan SS and Ren EC Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay 2006 BMC Infect Dis 6: 40. 
PubMed link
Stephenson I, Gust I, Pervikov Y and Kieny MP Development of vaccines against influenza H5 2006 Lancet Infect Dis 6(8): 458-460. 
PubMed link
Hayden F, Klimov A, Tashiro M, Hay A, Monto A, McKimm-Breschkin J, Macken C, Hampson A, Webster RG, Amyard M and Zambon M Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses 2005 Antivir Ther 10(8): 873-877. 
PubMed link
Alexander R, Hurt AC, Lamb D, Wong FY, Hampson AW and Barr IG A comparison of a rapid test for influenza with laboratory-based diagnosis in a paediatric population 2005 Commun Dis Intell 29(3): 272-276. 
PubMed link
Barr IG, Komadina N, Hurt AC, Iannello P, Tomasov C, Shaw R, Durrant C, Sjogren H and Hampson AW An influenza A(H3) reassortant was epidemic in Australia and New Zealand in 2003 2005 J Med Virol 76(3): 391-397. 
PubMed link
Berlioz-Arthaud A and Barr IG Laboratory-based influenza surveillance in New Caledonia, 1999-2003 2005 Trans R Soc Trop Med Hyg 99(4): 290-300. 
PubMed link
Li J, Hampson A, Roche PW, Yohannes K and Spencer JD Annual report of the National Influenza Surveillance Scheme, 2004 2005 Commun Dis Intell 29(2): 125-136. 
PubMed link
Cheam AL, Barr IG, Hampson AW, Mosse J and Hurt AC In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors 2004 Antiviral Res 63(3): 177-181. 
PubMed link
Ferson MJ, Morgan K, Robertson PW, Hampson AW, Carter I and Rawlinson WD Concurrent summer influenza and pertussis outbreaks in a nursing home in Sydney, Australia 2004 Infect Control Hosp Epidemiol 25(11): 962-966. 
PubMed link
Guy RJ, Di Natale R, Kelly HA, Lambert SB, Tobin S, Robinson PM, Tallis G and Hampson AW Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy 2004 Med J Aust 180(12): 640-642. 
PubMed link
Hurt AC, Barr IG, Hartel G and Hampson AW Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir 2004 Antiviral Res 62(1): 37-45. 
PubMed link
Hurt AC, Barr IG, Komadina N and Hampson AW A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses 2004 Virus Res 103(1-2): 79-83. 
PubMed link
Hurt AC, McKimm-Breschkin JL, McDonald M, Barr IG, Komadina N and Hampson AW Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs 2004 Virus Res 103(1-2): 205-211. 
PubMed link
Isaacs D, Dwyer DE and Hampson AW Avian influenza and planning for pandemics 2004 Med J Aust 181(2): 62-63. 
PubMed link
Stone B, Burrows J, Schepetiuk S, Higgins G, Hampson A, Shaw R and Kok T Rapid detection and simultaneous subtype differentiation of influenza A viruses by real time PCR 2004 J Virol Methods 117(2): 103-112. 
PubMed link
Yohannes K, Roche P, Hampson A, Miller M and Spencer J Annual report of the National Influenza Surveillance Scheme, 2003 2004 Commun Dis Intell 28(2): 160-168. 
PubMed link
Barr IG, Komadina N, Hurt A, Shaw R, Durrant C, Iannello P, Tomasov C, Sjogren H and Hampson AW Reassortants in recent human influenza A and B isolates from South East Asia and Oceania 2003 Virus Res 98(1): 35-44. 
PubMed link
Hampson A Future perspectives 2003 Dev Biol (Basel) 115: 145-151. 
PubMed link
Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM and Hampson AW Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia 2003 Commun Dis Intell 27(4): 542-547. 
PubMed link
McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, Hayden F and Zambon M Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir 2003 Antimicrob Agents Chemother 47(7): 2264-2272. 
PubMed link
Nguyen-Van-Tam JS and Hampson AW The epidemiology and clinical impact of pandemic influenza 2003 Vaccine 21(16): 1762-1768. 
PubMed link
Yohannes K, Roche P, Spencer J and Hampson A Annual report of the National Influenza Surveillance Scheme, 2002 2003 Commun Dis Intell 27(2): 162-172. 
PubMed link
Hampson AW Pandemic influenza: history, extent of the problem and approaches to control 2002 Dev Biol (Basel) 110: 115-123. 
PubMed link
Roche P, Spencer J and Hampson A Annual report of the National Influenza Surveillance Scheme, 2001 2002 Commun Dis Intell 26(2): 204-213. 
PubMed link
Gust ID, Hampson AW and Lavanchy D Planning for the next pandemic of influenza 2001 Rev Med Virol 11(1): 59-70. 
PubMed link
Layne SP, Beugelsdijk TJ, Patel CK, Taubenberger JK, Cox NJ, Gust ID, Hay AJ, Tashiro M and Lavanchy D A global lab against influenza 2001 Science 293(5536): 1729. 
PubMed link
Roche P, Spencer J, Merianos A and Hampson A Annual report of the National Influenza Surveillance Scheme, 2000 2001 Commun Dis Intell 25(3): 107-112. 
PubMed link
Thomson J, Lin M and Hampson A Annual report of the National Influenza Surveillance Scheme, 1999 2000 Commun Dis Intell 24(6): 145-152. 
PubMed link
Halliday L, Roberts L and Hampson A Annual report of the National Influenza Surveillance Scheme, 1998 1999 Commun Dis Intell 23(7): 185-192. 
PubMed link
Hampson AW Influenza surveillance in Australia 1999 Vaccine 17 Suppl 1: S113-114. 
PubMed link
Hampson AW Vaccination of the older adult: the Australian experience 1999 Vaccine 17 Suppl 1: S63-66. 
PubMed link
Hampson AW Epidemiological data on influenza in Asian countries 1999 Vaccine 17 Suppl 1: S19-23. 
PubMed link
McMinn P, Carrello A, Cole C, Baker D and Hampson A Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community 1999 Clin Infect Dis 29(2): 456-458. 
PubMed link
Ziegler T, Hemphill ML, Ziegler ML, Perez-Oronoz G, Klimov AI, Hampson AW, Regnery HL and Cox NJ Low incidence of rimantadine resistance in field isolates of influenza A viruses 1999 J Infect Dis 180(4): 935-939. 
PubMed link
Curran M and Hampson A National influenza surveillance 1997 1998 Commun Dis Intell 22(5): 69-74. 
PubMed link
Ada GL, Tannock GA and Hampson AW Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996) 1997 Vaccine 15(3): 245-247. 
PubMed link
Fedson DS, Hirota Y, Shin HK, Cambillard PE, Kiely J, Ambrosch F, Hannoun C, Leese J, Sprenger MJ, Hampson AW, Bro-Jorgensen K, Ahlbom AM, Nokleby H, Valle M, Olafsson O, Salmeron F, Cloetta J, Rebelo de Andrade H, Snacken R, Donatelli I, Jennings LC and Strikas RA Influenza vaccination in 22 developed countries: an update to 1995 1997 Vaccine 15(14): 1506-1511. 
PubMed link
Hampson AW Surveillance for pandemic influenza 1997 J Infect Dis 176 Suppl 1: S8-13. 
PubMed link
Hampson AW and Irving LB Influenza vaccination: cost-effective health care for the older adult? 1997 J Qual Clin Pract 17(1): 3-11. 
PubMed link
Sahasrabudhe A, Ekkel S, Hampson AW and McKimm-Breschkin JL Use of oligonucleotide probes for selecting potential high-yielding influenza reassortants 1997 J Virol Methods 68(2): 139-145. 
PubMed link
Carnie JA and Hampson AW Improving influenza vaccine coverage. Where we are and where we should be heading 1996 Aust Fam Physician 25(3): 269-271. 
PubMed link
Fedson DS, Hannoun C, Leese J, Sprenger MJ, Hampson AW, Bro-Jorgensen K, Ahlbom AM, Nokelby H, Valle M, Olafsson O and et al. Influenza vaccination in 18 developed countries, 1980-1992 1995 Vaccine 13(7): 623-627. 
PubMed link
center>

Top of Page